GoCheck Kids, the provider of a pediatric vision screener application that detects amblyopia risk factors in pre-verbal children, has clinched USD 6 million in Series B round. According to the announcement, the fresh capital will be utilized to add Artificial Intelligence capabilities with Apple’s CoreML and ARKit, as well as stimulate Electronic Health Records (EHR) integrations. The funding round was led by FCA Venture Partners, along with other new investors, Mucker Capital and Sovereign’s Capital will join the company’s existing investors, including Interwest Partners and Marc Benioff.
Amblyopia is the leading cause of monocular visual impairment for children in the US, a leading cause of childhood vision impairment worldwide, and affects about 1%–4% of preschool-aged children in the US, according to the Centers for Disease Control and Prevention (CDC). GoCheck Co-founder and CIO and leads innovation for the GoCheck Kids technology David Huang said that many childhood eye diseases, including amblyopia, myopia (near-sighted), hyperopia (far-sighted), and even retinoblastoma (rare but fatal childhood cancer) are not readily apparent or easily diagnosed by health care professionals. He further noted that Instrument-based vision screening has proven effective in identifying vision issues in children, however, it is cost-prohibitive for many pediatricians. We are changing this dynamic by bringing pediatric vision screening into the digital age.
GoCheck Kids, which was co-founded by David Huang back in 2013, is the first FDA-registered (U.S. Food and Drug Administration) iPhone application to screen the one in four children under six years old that have a correctable vision impairment, including amblyopia. GoCheck Kids makes early screening affordable and reducing the cost by over 60 percent by leveraging the iPhone’s manufacturing scale and bi-directional EHR integrations.